Interventions · Entity Annotation Prototype (beta)

1articles mentioning interventions

1intervention mentions

1distinct interventions extracted

0%of mentions human-reviewed

Active filtersEntity: Risk Evaluation and Mitigation Strategy (REMS) programme ×

Risk Evaluation and Mitigation Strategy (REMS) programme

This intervention is selected. Its supporting articles are shown below.

Risk Evaluation and Mitigation Strategy (REMS) programme1

Articles mentioning Risk Evaluation and Mitigation Strategy (REMS) programme

1 articles · page 1 of 1

Risk of neutropenia-related hospitalisation among clozapine initiators

ebmental · abstract · 2026-02-06 · 1 matching annotations

85.6%

Risk Evaluation and Mitigation Strategy (REMS) programme Clozapine olanzapine schizophrenia agranulocytosis Medicaid schizoaffective disorder Food and Drug Administration

…o regular blood testing to monitor for neutropenia as part of a Risk Evaluation and Mitigation Strategy (REMS) programme.Objective This study sought to compare the risk of neutropenia-…

Browse interventions

Risk Evaluation and Mitigation Strategy (REMS) programme

Articles mentioning Risk Evaluation and Mitigation Strategy (REMS) programme

Risk of neutropenia-related hospitalisation among clozapine initiators